About BCU CME Meetings Special Editions Meet The Professors Patterns of Care Conference Partnerships Patient Projects Other Tumor Types About us
You are here: Home: BCU 5 | 2008: Peter M Ravdin, MD, PhD - Select Publications

Select Publications

Albain K et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, ER-positive breast cancer (S8814,INT0100). San Antonio Breast Cancer Symposium 2007;Abstract 10.

Cardoso F et al. Clinical application of the 70-gene profile: The MINDACT trial. J Clin Oncol 2008;26(5):729-35. Abstract

Gnant M et al. Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12. Proc ASCO 2008;Abstract LBA4.

Paik S et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-34. Abstract

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table of Contents Top of Page

BCU Think Tank

CME Test Online

Home · Search

EDITOR
Neil Love, MD

INTERVIEWS
Nancy E Davidson, MD
- Select publications

Professor John Crown, MD
- Select publications

Kathy D Miller, MD
- Select publications

Peter M Ravdin, MD, PhD
- Select publications

THREE PERSPECTIVES ON US COOPERATIVE GROUP RESEARCH

Norman Wolmark, MD
- Select publications

Joyce O’Shaughnessy, MD
- Select publications

Eric P Winer, MD
- Select publications

 

Breast Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures

Editor's Office

Media Center
PDF
Media Center
Podcast
Previous Editions
Home Terms and Conditions of Use and General Disclaimer | Privacy Policy
Copyright © 2008 Research To Practice. All Rights Reserved